Brought to you by:
VESS 2022: Novel use of TCAR to treat complex brachiocephalic disease shown to be effective, researchers report
A “unique” case series of patients undergoing transcarotid artery revascularization (TCAR) in which the system was put to novel use for proximal intervention or incorporated in a hybrid approach to complex brachiocephalic disease demonstrated it to be effective in “providing…
TCAR affords greater quality-adjusted life years than carotid endarterectomy, cost-effectiveness model finds
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded greater quality-adjusted life years (QALY). The study was published in the December 2021 issue of the…
SVS issues new guidelines covering carotid disease and popliteal aneurysms
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines for the management of extracranial cerebrovascular disease and popliteal artery aneurysms in a special supplement, “The Care of Patients with Extracranial Cerebrovascular Disease and Popliteal Artery Aneurysms: The…
‘TCAR yields high technical success with an extraordinarily low stroke and death rate at one year’
Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularization (TCAR) treatment for carotid stenosis in the ROADSTER 2 trial showed a 97.4% rate of technical success, no incidences of ipsilateral stroke and a…
Study detects no difference in adverse outcomes from balloon dilatation strategy used during TCAR
Avoiding a strategy of post-stent balloon dilation during transcarotid artery revascularization (TCAR) may be unnecessary—a “contradistinction” to results shown in conventional transfemoral carotid artery stenting, new research has shown. Jones Thomas, MD, an integrated vascular surgery resident at University Hospitals…
TCAR may be associated with favorable outcomes in restenotic carotid lesions, study suggests
Transcarotid artery revascularization (TCAR) may be associated with favorable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy (CEA), suggests a study that also evaluated in-hospital outcomes of transfemoral carotid artery stenting (TFCAS) and redo-CEA. Writing in…
Analysis shows TCAR is more cost effective than CAS for carotid stenosis
Transcarotid artery revascularization (TCAR) produces similar outcomes to the gold standard treatment for carotid stenosis—carotid endarterectomy (CEA)—but comes at a greater cost. This was among the conclusions presented by Sheila M. Coogan, MD, at the Vascular Annual Meeting (VAM) in…
TCAR has ‘statistically equivalent’ stroke and death outcomes to CEA, new study finds
Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularization (TCAR) for atherosclerotic carotid disease. The data were presented at the Society for Vascular Surgery (SVS) 2021 Vascular Annual Meeting…
VAM: Industry-sponsored symposia
Industry-sponsored symposia at the Vascular Annual Meeting (VAM) will be presented Wednesday and Thursday evenings and at three breakfast sessions taking place Thursday morning. Industry-supported evening Satellite Symposia will be held from 6:30 to 8 p.m. Wednesday and Thursday. Wednesday’s…
VESS session: ‘Concerted effort’ made to feature science, discussion from widest possible swath of US
At its very essence, says Vascular & Endovascular Surgery Society (VESS) President Jason T. Lee, MD, vascular surgery is a “social sport.” The specialty is built on the backs of not just the “alpha point guard,” or the surgeon, but…